|
Glioblastoma
|
|
|
|
|
Susan L. Chua, Mark A. Rosenthal, Shirley S. Wong, David
M. Ashley, Anne-marie Woods, Anthony Dowling, and Lawrence M. Cher
Phase 2 study of temozolomide
and Caelyx in patients with recurrent glioblastoma multiforme
Neuro-Oncology,
January 2004, Volume 6 Number 1, Pages 38 -- 43
|
|
S.
L. Chua, M. A. Rosenthal, D. Ashley, A.-M. Woods, A. Dowling, L. Cher
Combination
temozolomide (T) and pegylated liposomal doxorubicin (C) in patients with
recurrent glioblastoma multiforme (GBM)
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
|
|
P. Hau,
T. Jauch, B. Hirschmann, E. Drechsel, O. Grauer, H. Koch, C. Wismeth, A.
Steinbrecher, U. Bogdahn
Adjuvant chemotherapy with
temozolomide and pegylated liposomal doxorubicin in the first-line therapy
of patients with glioblastoma – a phase-II trial
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1547
|
|
P.
Hau, T. Jauch, U. Baumgart, O. Grauer, B. Hirschmann, L. Kaes, H.
Koch, C. Wismeth, A. Steinbrecher, U. Bogdahn
Adjuvant
chemotherapy with temozolomide and liposomal doxorubicine in the
first-line therapy of patients with glioblastoma - a phase-II trial
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
471
|
|
|
Gliomas
|
|
|
|
Marco Balzarotti, Emilio Ciusani, Chiara Calatozzolo, Danilo Croci,
Amerigo Boiardi, and Andrea Salmaggi
Effect of Association of Temozolomide With Other
Chemotherapic Agents on Cell Growth Inhibition in Glioma Cell Lines
Oncology Research, 2004, Volume 14, pp. 325-330
|
|
Hau P, Fabel K, Baumgart U, Rummele P, Grauer O,
Bock A, Dietmaier C, Dietmaier W, Dietrich J, Dudel C, Hubner F, Jauch T,
Drechsel E, Kleiter I, Wismeth C, Zellner A, Brawanski A, Steinbrecher A,
Marienhagen J, Bogdahn U
Pegylated liposomal doxorubicin-efficacy in
patients with recurrent high-grade glioma
Cancer. 2004 Mar 15;100(6):1199-207
|
|
Peter
Hau, Joerg Dietrich, Klaus Fabel, Ulrike Baumgart, Oliver Grauer,
Tanya Jauch, Anton Zellner, Martin Proescholdt, Andreas Steinbrecher,
Alexander Brawanski, Peter Krauseneck, Ulrich Bogdahn
Liposomal
doxorubicin with and without tamoxifen in the salvage treatment of high
grade glioma - a phase-II study
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
312
|
|
|
Metastatic
Tumors
|
|
|
|
M. Caraglia, R. Addeo, R.
Costanzo, L. Montella, V. Faiola, E. Capasso, S. Del Prete
Pegylated liposomal doxorubicin
plus temozolamide in the salvage treatment of brain metastases: The update
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1576
|
|
S.
Del Prete, M. Caraglia, R. Addeo, R. Costanzo, V. Faiola, G. Facchini
Pegylated
liposomal doxorubicin plus temozolamide in the salvage treatment of brain
metastases: A feasibility study
39th ASCO Annual
Meeting. Chicago, IL. May 31-June 3, 2003.
|
|
|
Non-Nervous
System Tumors
|
|
|
|
Scambia G, De Vincenzo R, Ranelletti
FO, Panici PB, Ferrandina G, D'Agostino G, Fattorossi A, Bombardelli
E,
Mancuso S
Antiproliferative
effect of silybin on gynaecological malignancies: synergism with
cisplatin and doxorubicin
Eur J Cancer. 1996
May;32A(5):877-82
|
|
